A Randomized Trial Evaluating Control-IQ+ Technology in Adults With Type 2 Diabetes

NCT05785832 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

319

Enrollment

INDUSTRY

Sponsor class

Conditions

Type 2 Diabetes Treated With Insulin

Interventions

DEVICE: t:slim X2 insulin pump with Control-IQ+ technology and Dexcom G6 CGM
DEVICE: Standard Therapy plus continuous glucose monitoring (CGM)

Sponsor

Tandem Diabetes Care, Inc.

Collaborators

[object Object]